Pathstone Holdings’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.52M Sell
112,338
-5,561
-5% -$448K 0.03% 421
2026
Q1
$8.34M Sell
117,899
-11,957
-9% -$895K 0.03% 398
2025
Q4
$10.3M Buy
129,856
+102
+0.1% +$8.07K 0.04% 334
2025
Q3
$10.7M Sell
129,754
-2,503
-2% -$197K 0.04% 317
2025
Q2
$10.6M Sell
132,257
-9,870
-7% -$762K 0.04% 309
2025
Q1
$11.4M Buy
142,127
+2,057
+1% +$171K 0.05% 299
2024
Q4
$11.5M Sell
140,070
-774
-0.5% -$64.4K 0.05% 258
2024
Q3
$11.6M Sell
140,844
-1,664
-1% -$124K 0.05% 281
2024
Q2
$10M Sell
142,508
-2,247
-2% -$160K 0.05% 298
2024
Q1
$10.7M Buy
144,755
+6,967
+5% +$486K 0.05% 283
2023
Q4
$9.12M Buy
+137,788
New +$8.62M 0.05% 274

Other funds holding MET

Pathstone Holdings's MET Position: Q2 2026 in Review

Pathstone Holdings reduced its MetLife (MET) stake by 4.7% in Q2 2026, selling an estimated $448K and leaving 112,338 shares worth $9.52M. The position accounts for 0.03% of the portfolio, ranked #421.

Pathstone Holdings first reported a position in MET in Q4 2023 and has held it in 11 quarters since. The position peaked at $11.6M in Q3 2024. 1,442 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Pathstone Holdings held 112,338 shares of MetLife worth $9.52M as of Q2 2026.
  • Pathstone Holdings sold 5,561 MetLife shares in Q2 2026, an estimated $448K.
  • MetLife made up 0.03% of Pathstone Holdings's portfolio in Q2 2026, its #421 holding.
  • Pathstone Holdings first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • Pathstone Holdings's MetLife position peaked at $11.6M in Q3 2024.
  • 1,442 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.